Per Soelberg Sørensen
Professor emeritus, Professor, emeritus
- 2009
- Published
Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP
Hedegaard, C. J., Chen, N., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg, Leslie, R. G. Q., Bendtzen, K. & Nielsen, Claus Henrik, 1 Sep 2009, In: Immunology. 128, 1 Suppl, p. e451-61Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1
Enevold, C., Oturai, A. B., Sørensen, Per Soelberg, Ryder, L. P., Koch-Henriksen, N. & Bendtzen, K., 25 Jul 2009, In: Journal of Neuroimmunology. 212, 1-2, p. 125-31 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis
Ravnborg, M., Bendtzen, K., Christensen, O., Jensen, P. E. H., Hesse, D., Tovey, M. G. & Sørensen, Per Soelberg, 1 Mar 2009, In: Multiple Sclerosis. 15, 3, p. 323-8 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
How effective is natalizumab as second-line treatment for multiple sclerosis in daily clinical praxis?
Sørensen, Per Soelberg, 2009, In: European Journal of Neurology. 16, 3, p. 287-288 1 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation
Sellebjerg, Finn Thorup, Krakauer, M., Hesse, D., Ryder, L. P., Alsing, I., Jensen, P. E., Koch-Henriksen, N., Svejgaard, A., Sorensen, P. S., Sellebjerg, Finn Thorup, Krakauer, M., Hesse, D., Ryder, L. P., Alsing, I., Jensen, P. E. H., Koch-Henriksen, N., Svejgaard, A. & Sørensen, Per Soelberg, 2009, In: European Journal of Neurology. 16, 12, p. 1291-8 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
Sellebjerg, Finn Thorup, Börnsen, L., Khademi, M., Krakauer, M., Olsson, T., Frederiksen, J. L., Sørensen, P. S., Sellebjerg, Finn Thorup, Börnsen, L., Khademi, M., Krakauer, M., Olsson, T., Battistini, J. L. & Sørensen, Per Soelberg, 2009, In: Neurology. 73, 23, p. 2003-10 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Management of patients with neutralizing antibodies against interferon-beta: stop IFN-beta therapy or wait for the antibodies to go away?
Sørensen, Per Soelberg, 2009, In: European Journal of Neurology. 16, 1, p. 1-2 1 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Methylprednisolone does not restore biological response in multiple sclerosis patients with neutralizing antibodies against interferon-beta
Hesse, D., Frederiksen, J. L., Koch-Henriksen, N., Schreiber, K., Stenager, E., Heltberg, A., Ravnborg, M., Bendtzen, K., Sellebjerg, Finn Thorup, Sorensen, P. S., Hesse, D., Battistini, J. L., Koch-Henriksen, N., Schreiber, K., Stenager, E., Heltberg, A., Ravnborg, M., Bendtzen, K., Sellebjerg, Finn Thorup & Sørensen, Per Soelberg, 2009, In: European Journal of Neurology. 16, 1, p. 43-7 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial
Sorensen, P. S., Mellgren, S. I., Svenningsson, A., Elovaara, I., Frederiksen, J. L., Beiske, A. G., Myhr, K., Søgaard, L. V., Olsen, I. C., Sandberg-Wollheim, M., Sørensen, Per Soelberg, Mellgren, S. I., Svenningsson, A., Elovaara, I., Battistini, J. L., Beiske, A. G., Myhr, K., Søgaard, L. V., Olsen, I. C. & Sandberg-Wollheim, M., 2009, In: Lancet Neurology. 8, 6, p. 519-29 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 11025
Most downloads
-
245
downloads
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
187
downloads
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
162
downloads
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies
Research output: Contribution to journal › Journal article › Research › peer-review
Published